Introduction: “Over-prescription” is defined as the action of prescribing a drug or treatment in greater amount or on more occasions than necessary. Overprescribing, in general in health care, has been […]readmore
Tags : Antibiotics
In late 2019, a mysterious virus causing infection consisting of dry cough, fever tiredness, and last pneumonia first appeared in Wuhan, China. The world health organization (WHO) named the disease […]readmore
Shots: Qpex Biopharm to receive up front, development, regulatory and commercial milestones with royalties on sales in the licensed territories. Brii Biosciences to get the license to develop, manufacture, and […]readmore
Shots: Nosopharm and Evotec collaborated to advance Nosopharm’s NOSO-502 to clinical stage and to develop second-generation Odilorhabdin (ODLs) for hospital-acquired pneumonia and ventilation-associated pneumonia (HAP/VAP), under the name NOSO-2G The […]readmore
Shots: Eli Lilly to receive $75M upfront & $300M on the completion of transaction. Eddingpharm to get exclusive rights for Lilly’s two antibiotics, Ceclor and Vancocin and a manufacturing facility […]readmore
Shots: Evotec and GARDP enter into an agreement to develop novel therapies for growing threat of antimicrobial resistance (AMR) The focus of the collaboration is to combine GARDP’s clinical expertise […]readmore